including the launch of an unbranded insulin glargine last year at a 60% discount to Lantus and the introduction of a $35 co-pay cap for people without insurance. The head of Sanofi’s general ...

Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule ...

Pharmaceutical company Novo Nordisk has announced it ... Zilbermint highlights Lantus (insulin glargine) as a good option. Although Levermir and Lantus have different chemical structures, both ...

Generic drugmaker Viatris has become the first company to secure FDA approval ... reference product – namely Sanofi's once-daily insulin Lantus. Semglee has been approved for over a year as ...

The pharmaceutical company, which makes drugs like Lantus insulin jabs and Plavix blood thinners, spends about three billion euros, or $3.1 billion, on discovery within that timeframe, Hudson said.

Coverage can vary among plans sponsored by the same insurance company ... as Lantus or Novolog, a pop-up box notes, “Your drug has a generic” that may cost less. In the case of insulin ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Telehealth platform GoodRx has become the latest company to offer people with ... patients a coupon for to a 30-day supply of Lantus, an insulin glargine injection and Sanofi's most widely ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...